- Home
- MNPR vs CXE Comparison
MNPR vs CXE Comparison
Compare MNPR & CXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CXE
- Stock Information
- Founded
- MNPR 2014
- CXE 1989
- Country
- MNPR United States
- CXE United States
- Employees
- MNPR N/A
- CXE N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CXE Investment Managers
- Sector
- MNPR Health Care
- CXE Finance
- Exchange
- MNPR Nasdaq
- CXE Nasdaq
- Market Cap
- MNPR 113.5M
- CXE 122.3M
- IPO Year
- MNPR 2019
- CXE N/A
- Fundamental
- Price
- MNPR $30.68
- CXE $3.74
- Analyst Decision
- MNPR Strong Buy
- CXE
- Analyst Count
- MNPR 3
- CXE 0
- Target Price
- MNPR $27.33
- CXE N/A
- AVG Volume (30 Days)
- MNPR 93.6K
- CXE 62.9K
- Earning Date
- MNPR 11-08-2024
- CXE 01-01-0001
- Dividend Yield
- MNPR N/A
- CXE 4.36%
- EPS Growth
- MNPR N/A
- CXE N/A
- EPS
- MNPR N/A
- CXE 0.07
- Revenue
- MNPR N/A
- CXE N/A
- Revenue This Year
- MNPR N/A
- CXE N/A
- Revenue Next Year
- MNPR N/A
- CXE N/A
- P/E Ratio
- MNPR N/A
- CXE $51.00
- Revenue Growth
- MNPR N/A
- CXE N/A
- 52 Week Low
- MNPR $1.55
- CXE $2.95
- 52 Week High
- MNPR $38.50
- CXE $3.67
- Technical
- Relative Strength Index (RSI)
- MNPR 76.63
- CXE 33.13
- Support Level
- MNPR $20.16
- CXE $3.76
- Resistance Level
- MNPR $25.97
- CXE $3.91
- Average True Range (ATR)
- MNPR 2.75
- CXE 0.05
- MACD
- MNPR 0.41
- CXE -0.01
- Stochastic Oscillator
- MNPR 90.25
- CXE 0.00
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CXE MFS High Income Municipal Trust
Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.